brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
jaypirca
eli lilly nederland b.v. - pirtobrutinib - limfom, mantle cell - proteinska kinaza inhibitorji - treatment of mantle cell lymphoma (mcl).
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
rutacid 500 mg žvečljive tablete
krka, d.d., novo mesto - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit
rutacid 500 mg žvečljive tablete
krka, d.d., novo mesto - hidrotalcit - žvečljiva tableta - hidrotalcit 500 mg / 1 tableta - hidrotalcit
ibrutinib npp trde kapsule
kemofarmacija d.d. - kapsula, trda - ibrutinib
ibrutinib npp trde kapsule
kemofarmacija d.d. - kapsula, trda - ibrutinib
clarosip 187,5 mg zrnca za peroralno suspenzijo
zrnca za peroralno suspenzijo - klaritromicin
clarosip 250 mg zrnca za peroralno suspenzijo
zrnca za peroralno suspenzijo - klaritromicin
clarosip 125 mg zrnca za peroralno suspenzijo
zrnca za peroralno suspenzijo - klaritromicin